UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 October 10, 2003 Date of report (date of earliest event reported) QUADRAMED CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 0-21031 52-1992861 (State or Other (Commission File Number) (IRS Employer Jurisdiction Identification No.) of Incorporation) 12110 SUNSET HILLS ROAD, RESTON, VA 20190 (Address of Principal Executive Offices) (Zip Code) (703) 709-2300 (Registrant's Telephone Number, Including Area Code) ITEM 5. Other Items. ----------- QuadraMed Corporation ("QuadraMed") released a press release on October 10, 2003 and distributed a letter to employees and customers providing an update regarding the status of the ongoing SEC investigation ITEM 7. Exhibit. ------- Exhibit No. Description ---------- ----------- 99.1 QuadraMed Press Release dated October 10, 2003 entitled, "Quadramed Provides Update on SEC Investigation" 99.2 QuadraMed Letter to Employees dated October 13, 2003 99.3 Preliminary Draft - QuadraMed Letter to Customers dated October 13, 2003 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: October 13, 2003 QUADRAMED CORPORATION By: /s/ John C. Wright -------------------------- John C. Wright Executive Vice President and Corporate Secretary 2